Peritoneal Defenses Against Infection: Winning the Battle but Losing the War?

R. Faull

DOI: https://doi.org/10.1046/j.1525-139x.2000.00013.x

2000-01-01

Seminars in Dialysis

Abstract:Peritoneal dialysis continues to be only a shortto medium-term therapeutic option for most patients with end-stage renal failure (1, 2). The key to long-term success is maintaining the health and viability of the peritoneal membrane, which is at odds with expecting it to perform a function for which it was not specifically designed. The most common reason for failure is peritonitis, which is also a major cause of morbidity and mortality in this population (3, 4). In many cases, peritoneal dialysis has to be abandoned because of recurrent, overwhelming, and/or intractable peritoneal infection. In many other situations, though, the association between peritonitis and dialysis failure is more subtle and removed in time, where patients later develop slow onset of failure of dialysis function and/or ultrafiltration, or are later found to have increasing peritoneal cavity scarring (5, 6). The latter occasionally progresses to lifethreatening global sclerosis of the peritoneal cavity. Many of the advances in the techniques used for peritoneal dialysis have been driven by a desire to decrease the rate and severity of peritonitis, and on the whole they have been remarkably successful given that the physical isolation of the peritoneal cavity (one of its chief defenses against infection) is continuously breached. Unfortunately this success in reducing the rate of peritonitis (typically now to an average of less than 1 episode/year/ patient) has not translated into a striking increase in the duration of peritoneal dialysis viability, and it is in fact not uncommon for patients to experience dialysis failure without ever having suffered a clinical episode of peritonitis. To a certain extent, lack of long-term survival seems to be intrinsic to the technique itself, and chronic exposure of the peritoneal membrane to the unphysiological dialysis fluid (low pH, hyperosmolar, hyperglycemic, lactate buffered) is most likely the major cause of this disappointing situation. The properties of the peritoneal membrane deteriorate with increasing duration of peritoneal dialysis, leading to a gradual loss of ultrafiltration function that is characterized by increased absorption of solute (glucose), poor fluid clearance, and increased loss of protein into the dialysate (7). Patients with these high transport characteristics at the commencement of peritoneal dialysis, or those who develop them during the course of dialysis, have poorer technique and personal survival (7, 8). With that background in mind, this review summarizes the components of the immune defense of the peritoneal cavity and will discusses their possible role, as well as that of peritonitis, in the short-and long-term viability of the peritoneal membrane and of the technique of peritoneal dialysis.